Does the heel-rise test explain functional capacity in venous insufficiency?

Introduction Individuals with chronic venous insufficiency (CVI) have muscle pump dysfunction and reduced functionality. However, studies are inconsistent in proving whether a particular test can assess muscle functional capacity. Therefore, the aim of this study was to evaluate whether the heel-ris...

Full description

Bibliographic Details
Main Authors: Danielle Aparecida Gomes Pereira, Ana Clara Ribeiro Lages, Marluce Lopes Basílio, Monize Cristine de Oliveira Pires, Débora Pantuso Monteiro, Túlio Pinho Navarro
Format: Article
Language:English
Published: Editora Champagnat
Series:Fisioterapia em Movimento
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-51502015000100061&lng=en&tlng=en
Description
Summary:Introduction Individuals with chronic venous insufficiency (CVI) have muscle pump dysfunction and reduced functionality. However, studies are inconsistent in proving whether a particular test can assess muscle functional capacity. Therefore, the aim of this study was to evaluate whether the heel-rise test (HRT) is able to explain functional capacity in patients with CVI. Materials and methods Subjects with CVI aged between 20 and 59 years old were selected for this study. All participants were classified by means of the Clinical Anatomy Etiology Pathophysiology Classification of Chronic Venous Disease (CEAP). The HRT and the shuttle walk test (SWT) were performed. Descriptive statistics, Spearman correlation, linear models and regression variance analysis (one-way ANOVA) were used for data analysis. Significance was set at alpha ≤ 5%. Results 79 subjects were included in the study (38.79 ± 1.34 years). The HRT was able to explain functional capacity only in individuals aged between 50-59 years (R2 = 0.60, p = 0.0001). The heel-rise test was not sensitive to detect differences between the CEAP classes analyzed (p > 0.05). Conclusion The HRT was able to explain functional capacity in individuals aged between 50-59 years, and it can be applied in clinical practice for the functional evaluation of patients with CVI with mild severity in this age range.
ISSN:1980-5918